Video

Genomic testing in prostate cancer and personalized medicine

Author(s):

Urology Times staff

“The…state of genomic testing continues to evolve,” says Ketan K. Badani, MD.

In this video, Ketan K. Badani, MD, also shares what personalized medicine means to him. Badani is a professor of urology at Icahn School of Medicine at Mount Sinai, vice chairman of urology and robotic operations at Mount Sinai Health System, director of robotic surgery at Mount Sinai West, and the director of the Comprehensive Kidney Cancer Program At Mount Sinai Health System, New York.

Related Videos
3d rendered illustration - bladder | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Wayne Kuang, MD, answers a question during a Zoom video interview
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
Mohamad Baker Berjaoui, MD, answers a question during a Zoom video interview
Related Content
3d rendered genetic illustration of human dna under microscope created with generative ai technology | Image Credit: © Picture Studio - stock.adobe.com
December 24th 2024

Quiz: CUA guidelines on specimen and timing considerations with genetic testing

Patrick Campbell
Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.
NCCN reaffirms Prolaris’ prognostic value in prostate cancer
December 18th 2024

NCCN reaffirms Prolaris’ prognostic value in prostate cancer

Hannah Clarke
The inclusion of the test is supported by more than 25 studies demonstrating its clinical utility, including 2 studies published earlier this year.
DNA helix | Image Credit: © Siarhei - stock.adobe.com
December 17th 2024

Quiz: What CUA guidelines say about genomic profiling of tumors in prostate cancer

Patrick Campbell
Test your knowledge of this quiz on the Canadian Urological Association's recommendations for genomic profiling of tumors in prostate cancer.
DNA molecules | Image Credit: © vitstudio - stock.adobe.com
December 10th 2024

Quiz: CUA guidelines on germline genetic testing in prostate cancer

Patrick Campbell
Test your knowledge of this quiz on the Canadian Urological Association's recommendations for germline genetic testing in prostate cancer management.
Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC
November 26th 2024

Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC

Hannah Clarke
“Our study highlights the potential of epigenomic profiling from a simple blood draw to provide a real-time, non-invasive readout of PSMA expression that corresponds with treatment response," says Jacob E. Berchuck, MD.
Survey sheds light on international genetic testing patterns in prostate cancer
November 18th 2024

Survey sheds light on international genetic testing patterns in prostate cancer

Hannah Clarke
Data demonstrated wide variation in the proportion of patients recommended for testing and showed that barriers to testing remain.
© 2024 MJH Life Sciences

All rights reserved.